IRIS
MAZZOCCA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.339
AS - Asia 1.620
EU - Europa 1.140
SA - Sud America 339
AF - Africa 38
OC - Oceania 2
AN - Antartide 1
Totale 7.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.299
SG - Singapore 684
CN - Cina 439
BR - Brasile 288
SE - Svezia 233
HK - Hong Kong 232
IT - Italia 208
RU - Federazione Russa 195
DE - Germania 156
VN - Vietnam 137
GB - Regno Unito 75
FI - Finlandia 74
UA - Ucraina 55
FR - Francia 48
CA - Canada 21
IN - India 19
NL - Olanda 19
BE - Belgio 18
ID - Indonesia 18
AR - Argentina 17
BD - Bangladesh 16
IQ - Iraq 16
CI - Costa d'Avorio 13
ES - Italia 13
MX - Messico 13
EC - Ecuador 12
PL - Polonia 12
SA - Arabia Saudita 10
ZA - Sudafrica 9
AT - Austria 8
IE - Irlanda 8
IR - Iran 7
VE - Venezuela 7
JP - Giappone 6
LT - Lituania 6
LB - Libano 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
TR - Turchia 4
CO - Colombia 3
EG - Egitto 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KZ - Kazakistan 2
NO - Norvegia 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KI - Kiribati 1
LU - Lussemburgo 1
LV - Lettonia 1
MV - Maldive 1
MW - Malawi 1
MZ - Mozambico 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
TJ - Tagikistan 1
UG - Uganda 1
Totale 7.479
Salva come PNG Salva come JPEG
Città #
Fairfield 529
Ashburn 492
Woodbridge 443
Singapore 341
Houston 338
Chandler 329
Seattle 241
Hong Kong 229
Nyköping 192
Cambridge 190
Wilmington 182
Jacksonville 157
Ann Arbor 150
Beijing 133
Bari 92
Dallas 80
Los Angeles 65
Lawrence 63
Roxbury 62
Nanjing 56
New York 56
Ho Chi Minh City 48
Des Moines 42
Brooklyn 32
Inglewood 31
Santa Clara 30
Princeton 29
North Bergen 28
Munich 26
Hanoi 24
Buffalo 23
Boardman 22
Dearborn 22
Shenyang 21
Helsinki 18
Brussels 17
San Diego 17
Dong Ket 16
São Paulo 16
Jiaxing 15
London 15
Nanchang 15
Chicago 14
Guangzhou 14
Nuremberg 14
Abidjan 13
Hebei 13
Jakarta 13
Milan 13
Paris 13
Rio de Janeiro 12
Zhengzhou 12
Moscow 11
Eindhoven 10
Hangzhou 10
Jinan 10
Orem 10
Toronto 10
Boston 9
Changsha 9
Frankfurt am Main 9
Ningbo 9
Ostuni 9
San Mateo 9
The Dalles 9
Tianjin 9
Belo Horizonte 8
Council Bluffs 8
Dublin 8
Haiphong 8
Mexico City 8
Norwalk 8
Riyadh 8
Leawood 7
Porto Alegre 7
Redwood City 7
Taizhou 7
Turku 7
Ardabil 6
Columbus 6
Da Nang 6
Johannesburg 6
Mottola 6
San Francisco 6
Stockholm 6
Warsaw 6
Atlanta 5
Baghdad 5
Curitiba 5
Montreal 5
Pescara 5
Poplar 5
Rome 5
Salt Lake City 5
Shanghai 5
Tokyo 5
Vienna 5
Chennai 4
Dhaka 4
Dongguan 4
Totale 5.397
Salva come PNG Salva come JPEG
Nome #
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 165
Autotaxin is a novel molecular identifier of type I endometrial cancer 163
Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE 157
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D 157
Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells 154
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 151
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment 150
T(14;18) translocation in chronic hepatitis C virus infection 150
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology 147
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells 144
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. 142
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 138
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer 134
null 131
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 130
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer 130
Clinical Usefulness of Cancer Antigen 15-3 in Breast Cancer Patients Before and After Surgery 128
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm 126
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications 121
Sorafenib: 10 years after the first pivotal trial 117
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 114
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration 114
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions 113
Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond 111
cAMP-dependent protein kinase of mitochondria. Structure and possible role of the substrates 110
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease 108
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 107
Pathobiology of Hepatocellular Carcinoma and Clinical Impact 107
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 106
Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma 106
Frictional purpuric eruption associated with angiotensin II receptor blockers 104
The integrin, α6β1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells 104
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells 103
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro 103
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer 101
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L 101
Tetraspanin-enriched microdomains and hepatocellular carcinoma progression. 98
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth 97
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 96
The metastatic process: methodological advances and pharmacological challenges 96
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 95
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 90
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 87
The TGF-β signaling pathway as a pharmacological target in hepatocellular carcinoma 87
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function 87
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 86
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 85
Tetraspanins CD9 and CD81 are molecular partners of trimeric FcεRI on human antigen-presenting cells 84
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 83
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. 83
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 82
Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer 82
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines 81
Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated mets predict colorectal liver metastases outgrowth 80
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer 78
Inhibiting TGF-β signaling in hepatocellular carcinoma 75
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection 75
Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 74
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 71
Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance 70
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation 70
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth 70
Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin 68
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 68
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 67
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 67
Targeting TGF-βRI inhibits activation of β1 integrin and blocks vascular invasion in Hepatocellular Carcinoma (HCC) 60
Effect of change of interleukin-6 over time on gait speed response: Results from the lifestyle interventions and independence for elders study 59
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma 59
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 58
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice 58
Implications of the lysophosphatidic acid signaling axis in liver cancer 55
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma 51
The perplexity of targeting genetic alterations in hepatocellular carcinoma 51
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy 49
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy 47
Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis 45
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer 45
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 40
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 40
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells 20
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer 15
Chronic Inflammation in Obesity and Cancer Cachexia 8
The systemic evolutionary theory of the origin of cancer (SETOC): an update 7
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells 7
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance 3
New hypotheses for cancer generation and progression 3
The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System 2
Totale 7.761
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021513 0 0 0 0 0 105 49 65 51 118 78 47
2021/2022485 17 61 5 15 34 30 28 26 34 24 93 118
2022/2023814 122 107 68 66 94 95 10 99 109 4 30 10
2023/2024240 23 51 14 28 18 55 8 8 1 7 11 16
2024/20251.441 21 14 97 50 47 108 183 109 117 63 189 443
2025/20261.640 465 123 244 387 367 54 0 0 0 0 0 0
Totale 7.761